Direct advertisment created by G2, New Zealand for Arimidex, within the category: Pharmaceutical.
Can you pick which of your breast cancer patients will have a recurrence?
There’s no way to predict which of your patients will have recurring breast cancer. So it makes sense to treat all patients as women with some risk. Versus tamoxifen, Arimidex can improve every patient's chance of staying disease free.
“Say Less, Do More”: Words of Inspiration From the 2017 Clio Sports AwardsRead More
Inside the Agency
How DDB’s Ari Weiss And Keith Reinhard Are Embracing Ad Legend Bill Bernbach’s “Rebel Spirit”Read More
Ward+Robes Designer Gowns Offer Individuality for Hospitalized TeensRead More
Empathy, Observation, Openness: IDEO’s Roshi Givechi on the Narrative of Product DesignRead More